Successful Treatment of Chronic Hepatitis C with Triple Therapy in an Opioid Agonist Treatment Program

BACKGROUND: People who inject drugs (PWID) constitute 10 million people globally with hepatitis C virus, including many opioid agonist treatment patients. Little data exist describing clinical outcomes for patients receiving HCV treatment with direct-acting antiviral agents (DAAs) in opioid agonist...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Drug Policy
Main Authors: Litwin, Alain H., Soloway, Irene J., Cockerham-Colas, Lauren, Reynoso, Sheila, Heo, Moonseong, Tenore, Christopher, Roose, Robert J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4833390/
https://ncbi.nlm.nih.gov/pubmed/26341685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugpo.2015.08.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados